eMedicine Specialties > Neurology > Pediatric Neurology
Neonatal Seizures: Treatment & Medication
Updated: Nov 16, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Medical Care
Acute neonatal seizures should be treated aggressively.6 Controversy exists as to what is the optimal treatment for neonatal seizures.8
When clinical seizures are present, a rigorous workup to determine an underlying etiologic cause should be initiated quickly. The following points should be attended to:
- Electrolyte imbalances should be corrected through a central venous site. Hypocalcemia should be treated cautiously with calcium, since leakage of calcium into subcutaneous tissue can cause scarring.
- Obtain EEG when uncertain as to whether the observed events are epileptic or nonepileptic.
- When an inborn error of metabolism is suspected, discontinue feeding since feeding may exacerbate the seizures and encephalopathy. Institute intravenous solutions.
- Once these issues have been addressed, antiepileptic drug (AED) therapy should be considered. Phenobarbital is the initial drug of choice. If seizures persist, the use of phenytoin should be considered.
Consultations
Neurology consultation is recommended to help with the evaluation of seizures, EEG, video EEG monitoring, and management of anticonvulsant medications.
Medication
Antiepileptic medications should be instituted in an orderly and efficient manner (Painter et all 1999). Correct hypoglycemia, if present. Initial treatment with phenobarbital should be considered. If seizures persist, phenytoin should be added. Persistent seizures may require use of an intravenous benzodiazepine such as lorazepam or midazolam.
Anticonvulsants
These agents prevent seizure recurrence and terminate clinical and electrical seizure activity.
Phenobarbital (Luminal, Barbita)
Important to use minimal amount required and to wait for anticonvulsant effect to develop before giving second dose. Start with loading dose and continue with maintenance dosage.
Adult
Pediatric
Loading dose: 20 mg/kg/d IV
Maintenance dose: 5-8 mg/kg/d IV
May decrease phenytoin effects
No known contraindications for use in neonates
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
In prolonged therapy, evaluate hematopoietic, renal, hepatic, and other organ systems; exercise caution in fever, hyperthyroidism, diabetes mellitus, and severe anemia, since adverse reactions can occur; exercise caution in patients with myasthenia gravis or myxedema
Phenytoin (Dilantin)
Should be added to phenobarbital if seizures persist. May act in motor cortex where may inhibit spread of seizure activity. Activity of brainstem centers responsible for tonic phase of grand mal seizures also may be inhibited.
Adult
Pediatric
Initial dose: 20 mg/kg/d IV
Maintenance dose: 5-8 mg/kg/d IV
Barbiturates may decrease effects
No known contraindications for use in neonates
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Hemodynamic stability should be monitored during IV administration; therapeutic levels are often difficult to maintain via enteral administration in neonates
Lorazepam (Ativan)
Benzodiazepine anticonvulsant; use in cases refractory to phenobarbital and phenytoin. By increasing action of GABA, which is major inhibitory neurotransmitter in brain, may depress all levels of CNS, including limbic and reticular formation.
Adult
Pediatric
0.05-0.1 mg/kg IV, followed by 0.05-mg/kg increments until seizures controlled
Barbiturates may increase CNS toxicity
No known contraindications for use in neonates
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
With concurrent phenobarbital, monitor blood pressure and respiration
Vitamins
This agent may be effective in seizures refractory to medications already discussed. It is essential for normal DNA synthesis and cell function.
Pyridoxine (Nestrex)
Should be tried in patients not responding to above regimen. Patients with pyridoxine-dependent seizures respond immediately to pyridoxine.
Adult
Pediatric
50-100 mg IV with EEG monitoring to determine response
None reported
No known contraindications for use in neonates
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
None in neonates
More on Neonatal Seizures |
| Overview: Neonatal Seizures |
| Differential Diagnoses & Workup: Neonatal Seizures |
Treatment & Medication: Neonatal Seizures |
| Follow-up: Neonatal Seizures |
| Multimedia: Neonatal Seizures |
| References |
| « Previous Page | Next Page » |
References
Volpe JJ. Hypoxic-Ischemic Encephalopathy: Biochemical and Physiological Aspects. In: Neurology of the Newborn. 4th ed. Philadelphia: WB Saunders; 2000:217-276.
Scher MS, Trucco GS, Beggarly ME, et al. Neonates with electrically confirmed seizures and possible placental associations. Pediatr Neurol. Jul 1998;19(1):37-41. [Medline].
Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol. Aug 2007;62(2):112-20. [Medline].
Sheth RD, Hobbs GR, Mullett M. Neonatal seizures: incidence, onset, and etiology by gestational age. J Perinatol. Jan 1999;19(1):40-3. [Medline].
Vigevano F. Benign familial infantile seizures. Brain Dev. Apr 2005;27(3):172-7. [Medline].
Sheth RD, Buckley DJ, Gutierrez AR, et al. Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol. Apr 1996;19(2):165-70. [Medline].
Sheth RD. Electroencephalogram in developmental delay: specific electroclinical syndromes. Semin Pediatr Neurol. Mar 1998;5(1):45-51. [Medline].
Sankar R, Painter MJ. Neonatal seizures: after all these years we still love what doesn't work. Neurology. Mar 8 2005;64(5):776-7. [Medline].
Lombroso CT. Neonatal seizures: gaps between the laboratory and the clinic. Epilepsia. 2007;48 Suppl 2:83-106. [Medline].
Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. Aug 12 1999;341(7):485-9. [Medline].
Sheth RD. Electroencephalogram confirmatory rate in neonatal seizures. Pediatr Neurol. Jan 1999;20(1):27-30. [Medline].
Sheth RD. Frequency of neurologic disorders in the neonatal intensive care unit. J Child Neurol. Sep 1998;13(9):424-8. [Medline].
Sheth RD, Bodensteiner JB. Delayed postanoxic encephalopathy: possible role for apoptosis. J Child Neurol. Jul 1998;13(7):347-8. [Medline].
[Best Evidence] Pisani F, Sisti L, Seri S. A scoring system for early prognostic assessment after neonatal seizures. Pediatrics. Oct 2009;124(4):e580-7. [Medline].
Further Reading
Keywords
neonatal seizures, benign familial neonatal convulsions, benign neonatal convulsions, fifth day convulsions, fifth day fits, myoclonic seizures, newborn fits, hypoxic-ischemic encephalopathy, intracranial hemorrhage in a newborn, subarachnoid hemorrhage in infants, germinal matrix-intraventricular hemorrhage, subdural hemorrhage, cerebral contusion, metabolic disturbances, hypoglycemia, hypocalcemia, hypomagnesemia, meningitis, encephalitis, herpes encephalitis, toxoplasmosis, cytomegalovirus, CMV infection, lissencephaly, pachygyria, polymicrogyria, linear sebaceous nevus syndrome, benign neonatal seizure syndromes, benign idiopathic neonatal seizures, benign sleep myoclonus
Treatment & Medication: Neonatal Seizures